|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.085 EUR | +5.34% |
|
-0.91% | -17.18% |
| Jul. 01 | ITALY GROWTH WINNERS & LOSERS: Espe on top; Redfish bad | AN |
| Jun. 04 | Erfo, MIMIT grant facilities for Plants project. | AN |
Laboratorio Farmaceutico Erfo S.p.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 3.17 million compared to EUR 2.67 million a year ago. Revenue was EUR 3.48 million compared to EUR 2.79 million a year ago.
Net income was EUR 0.470253 million compared to EUR 0.476797 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.18% | 9.63M | |
| +62.59% | 841B | |
| +40.42% | 625B | |
| -3.87% | 360B | |
| +17.47% | 327B | |
| +10.34% | 300B | |
| +15.66% | 242B | |
| +17.90% | 227B | |
| +15.71% | 174B | |
| +1.02% | 162B |
LABORATORIO FARMACEUTICO ERFO S.P.A. 
